Asian Journal of Sports Medicine

Published by: Kowsar

The Prevalence and Characteristics of Performance-Enhancing Drug Use Among Bodybuilding Athletes in the South of Iran, Bushehr

Mohammad Javad Haerinejad 1 , Afshin Ostovar 1 , Mohamad Reza Farzaneh 2 and Mojtaba Keshavarz 3 , *
Authors Information
1 The Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, IR Iran
2 Department of Pathology, Bushehr University of Medical Sciences, Bushehr, IR Iran
3 Department of Pharmacology, Bushehr University of Medical Sciences, Bushehr, IR Iran
Article information
  • Asian Journal of Sports Medicine: September 01, 2016, 7 (3); e35018
  • Published Online: July 16, 2016
  • Article Type: Research Article
  • Received: November 25, 2015
  • Revised: April 11, 2016
  • Accepted: April 23, 2016
  • DOI: 10.5812/asjsm.35018

To Cite: Haerinejad M J, Ostovar A, Farzaneh M R, Keshavarz M. The Prevalence and Characteristics of Performance-Enhancing Drug Use Among Bodybuilding Athletes in the South of Iran, Bushehr, Asian J Sports Med. 2016 ; 7(3):e35018. doi: 10.5812/asjsm.35018.

Abstract
Copyright © 2016, Sports Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Pope HJ, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014; 35(3): 341-75[DOI][PubMed]
  • 2. Mason MA, Giza M, Clayton L, Lonning J, Wilkerson RD. Use of nutritional supplements by high school football and volleyball players. Iowa Orthop J. 2001; 21: 43-8[PubMed]
  • 3. Brennan BP, Kanayama G, Hudson JI, Pope HJ. Human growth hormone abuse in male weightlifters. Am J Addict. 2011; 20(1): 9-13[DOI][PubMed]
  • 4. Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ. Weightlifting's risky new trend: a case series of 41 insulin users. Curr Sports Med Rep. 2012; 11(4): 176-9[DOI][PubMed]
  • 5. Gregory AJ, Fitch RW. Sports medicine: performance-enhancing drugs. Pediatr Clin North Am. 2007; 54(4): 797-806[DOI][PubMed]
  • 6. Sjoqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet. 2008; 371(9627): 1872-82[DOI][PubMed]
  • 7. Pavlovic R, Idrizovic K. Attitudes of students of physical education and sports about doping in sport. Facta Univ Phys Educ Sport. 2013; 11(1): 103-13
  • 8. Pope HJ, Kanayama G, Hudson JI. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2012; 71(3): 254-61[DOI][PubMed]
  • 9. Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006; 38(4): 644-51[DOI][PubMed]
  • 10. Halabchi F. The knowledge of club wrestlers of tehran about doping and their assessment of the current prevalence in the country. J Sport Biosci. 2009; 1: 105-21
  • 11. Kargarfard M, Kashi A. Prevalence of use anabolic androgenic steroid and awareness of isfahan university students about their side effect. Quarterly J fundamentals mental health. 2007; 8(1-2): 73-82
  • 12. Kashi A, Kargarfard M, Mavlavi H, Sarlak Z. . Using of energetic drugs in athletes of body builder: prevalence, identification and Knowledge about their Side Effects of it. Olympic. 2006; 14(2): 73-86
  • 13. Kargarfard M, Kashi A, Sarlak Z. Prevalence of ergogenic substances use and athletes knowledge of effects and side effects of them in Lorestan province, western part of Iran. J Fundamentals of mental health. 2009; 2: 123-34
  • 14. Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy. 2011; 31(8): 757-66[DOI][PubMed]
  • 15. Nakhaee MR, Pakravan F, Nakhaee N. Prevalence of use of anabolic steroids by bodybuilders using three methods in a city of iran. Addict Health. 2013; 5(3-4): 77-82[PubMed]
  • 16. Bahrami S, Yousefi B, Kaviani E, Ariapooran S. The prevalence of energetic drugs use and the role of perfectionism, sensation seeking and physical self-concept in discriminating bodybuilders with positive and negative attitude toward doping. Int J Sport Studies. 2014; 4: 174-80
  • 17. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996; 335(1): 1-7[DOI][PubMed]
  • 18. Johannsson G, Marin P, Lonn L, Ottosson M, Stenlof K, Bjorntorp P, et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab. 1997; 82(3): 727-34[DOI][PubMed]
  • 19. Lovstakken K, Peterson L, Homer AL. Risk factors for anabolic steroid use in college students and the role of expectancy. Addict Behav. 1999; 24(3): 425-30[PubMed]
  • 20. Bahrke MS, Yesalis CE, Kopstein AN, Stephens JA. Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Med. 2000; 29(6): 397-405[PubMed]
  • 21. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS. Anabolic-androgenic steroid use in the United States. JAMA. 1993; 270(10): 1217-21[PubMed]
  • 22. Cohen J, Collins R, Darkes J, Gwartney D. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr. 2007; 4: 12[DOI][PubMed]
  • 23. Pope HG, Kanayama G, Ionescu-Pioggia M, Hudson JI. Anabolic steroid users' attitudes towards physicians. Addiction. 2004; 99(9): 1189-94[DOI][PubMed]
  • 24. Wright S, Sarah G, Hunter G. Body-builders' attitudes towards steroid use. Drugs: Education, Prevention and Policy. 2009; 8(1): 91-5[DOI]
  • 25. Leit RA, Pope HJ, Gray JJ. Cultural expectations of muscularity in men: the evolution of playgirl centerfolds. Int J Eat Disord. 2001; 29(1): 90-3[PubMed]
  • 26. Pope HJ, Olivardia R, Gruber A, Borowiecki J. Evolving ideals of male body image as seen through action toys. Int J Eat Disord. 1999; 26(1): 65-72[PubMed]
  • 27. Pope HJ, Gruber AJ, Mangweth B, Bureau B, deCol C, Jouvent R, et al. Body image perception among men in three countries. Am J Psychiatry. 2000; 157(8): 1297-301[DOI][PubMed]
  • 28. Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett. 2005; 158(3): 167-75[DOI][PubMed]
  • 29. Perry PJ, Lund BC, Deninger MJ, Kutscher EC, Schneider J. Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization. Clin J Sport Med. 2005; 15(5): 326-30[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments